106 related articles for article (PubMed ID: 29202377)
1. Quantifying the prognostic significance in glioblastoma of seizure history at initial presentation: A systematic review and meta-analysis.
Lu VM; Jue TR; Phan K; McDonald KL
Clin Neurol Neurosurg; 2018 Jan; 164():75-80. PubMed ID: 29202377
[TBL] [Abstract][Full Text] [Related]
2. The impact of hyperglycemia on survival in glioblastoma: A systematic review and meta-analysis.
Lu VM; Goyal A; Vaughan LS; McDonald KL
Clin Neurol Neurosurg; 2018 Jul; 170():165-169. PubMed ID: 29803727
[TBL] [Abstract][Full Text] [Related]
3. The Survival Effect of Repeat Surgery at Glioblastoma Recurrence and its Trend: A Systematic Review and Meta-Analysis.
Lu VM; Jue TR; McDonald KL; Rovin RA
World Neurosurg; 2018 Jul; 115():453-459.e3. PubMed ID: 29654958
[TBL] [Abstract][Full Text] [Related]
4. Older studies can underestimate prognosis of glioblastoma biomarker in meta-analyses: a meta-epidemiological study for study-level effect in the current literature.
Lu VM; Phan K; Yin JXM; McDonald KL
J Neurooncol; 2018 Sep; 139(2):231-238. PubMed ID: 29767813
[TBL] [Abstract][Full Text] [Related]
5. The survival effect of valproic acid in glioblastoma and its current trend: a systematic review and meta-analysis.
Lu VM; Texakalidis P; McDonald KL; Mekary RA; Smith TR
Clin Neurol Neurosurg; 2018 Nov; 174():149-155. PubMed ID: 30243186
[TBL] [Abstract][Full Text] [Related]
6. A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools.
Thuy MN; Kam JK; Lee GC; Tao PL; Ling DQ; Cheng M; Goh SK; Papachristos AJ; Shukla L; Wall KL; Smoll NR; Jones JJ; Gikenye N; Soh B; Moffat B; Johnson N; Drummond KJ
J Clin Neurosci; 2015 May; 22(5):785-99. PubMed ID: 25698544
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of seizure in patients with glioblastoma multiforme.
Ozbek N; Cakir S; Gursel B; Meydan D
Neurol India; 2004 Mar; 52(1):76-8. PubMed ID: 15069244
[TBL] [Abstract][Full Text] [Related]
8. Seizure prophylaxis in patients with brain tumors: a meta-analysis.
Sirven JI; Wingerchuk DM; Drazkowski JF; Lyons MK; Zimmerman RS
Mayo Clin Proc; 2004 Dec; 79(12):1489-94. PubMed ID: 15595331
[TBL] [Abstract][Full Text] [Related]
9. Comparative epidemiology of gliosarcoma and glioblastoma and the impact of Race on overall survival: A systematic literature review.
Gerges C; Elder T; Penuela M; Rossetti N; Maynard M; Jeong S; Wright CH; Wright J; Zhou X; Burant C; Sajatovic M; Hodges T
Clin Neurol Neurosurg; 2020 Aug; 195():106054. PubMed ID: 32650210
[TBL] [Abstract][Full Text] [Related]
10. Seizure prevalence, contributing factors, and prognostic factors in patients with leptomeningeal disease.
Zima LA; Tulpule S; Samson K; Shonka N
J Neurol Sci; 2019 Aug; 403():19-23. PubMed ID: 31176194
[TBL] [Abstract][Full Text] [Related]
11. Postoperative epilepsy in patients undergoing craniotomy for glioblastoma multiforme.
Telfeian AE; Philips MF; Crino PB; Judy KD
J Exp Clin Cancer Res; 2001 Mar; 20(1):5-10. PubMed ID: 11370829
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
13. High CD133 Expression Is Associated with Worse Prognosis in Patients with Glioblastoma.
Zhang W; Chen H; Lv S; Yang H
Mol Neurobiol; 2016 May; 53(4):2354-60. PubMed ID: 25983032
[TBL] [Abstract][Full Text] [Related]
14. Seizures at presentation are correlated with better survival outcomes in adult diffuse glioma: A systematic review and meta-analysis.
Fan X; Li Y; Shan X; You G; Wu Z; Li Z; Qiao H; Jiang T
Seizure; 2018 Jul; 59():16-23. PubMed ID: 29727741
[TBL] [Abstract][Full Text] [Related]
15. Association Between Tumor Compartment Volumes, the Incidence of Pretreatment Seizures, and Statin-Mediated Protective Effects in Glioblastoma.
Henker C; Kriesen T; Scherer M; Glass Ä; von Deimling A; Bendszus M; Weber MA; Herold-Mende C; Unterberg A; Piek J
Neurosurgery; 2019 Oct; 85(4):E722-E729. PubMed ID: 30888031
[TBL] [Abstract][Full Text] [Related]
16. Comparison of time taken from initial presentation to histological diagnosis of Glioblastoma Multiforme (GBM) in Birmingham, United Kingdom and Strasbourg, France.
Natalwala A; Bharkhada V; Noel G; Cruickshank G
Clin Neurol Neurosurg; 2011 Jun; 113(5):358-61. PubMed ID: 21470768
[TBL] [Abstract][Full Text] [Related]
17. The clinical effectiveness and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model.
Burch J; Hinde S; Palmer S; Beyer F; Minton J; Marson A; Wieshmann U; Woolacott N; Soares M
Health Technol Assess; 2012; 16(34):1-157, iii-iv. PubMed ID: 22985954
[TBL] [Abstract][Full Text] [Related]
18. Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.
Babu R; Komisarow JM; Agarwal VJ; Rahimpour S; Iyer A; Britt D; Karikari IO; Grossi PM; Thomas S; Friedman AH; Adamson C
J Neurosurg; 2016 Apr; 124(4):998-1007. PubMed ID: 26452121
[TBL] [Abstract][Full Text] [Related]
19. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of preoperative seizure in adult glioblastoma: A systematic review and meta-analysis.
Chen K; Duan P; Jiang P
Asian J Surg; 2021 Jul; 44(7):994-995. PubMed ID: 33965323
[No Abstract] [Full Text] [Related]
[Next] [New Search]
